![]() PNP Therapeutics PNP Therapeutics is a biopharmaceutical company engaged in the development of platform technology and proprietary products for the treatment of cancer. | ![]() Clovis Oncology Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents. | ![]() Peloton Therapeutics Peloton Therapeutics is involved in discovering and developing novel drugs for cancer treatments. | Revolution Medicines Revolution Medicines (RevMed) is a clinical-stage oncology company that develops therapies for cancer patients. | ||
Founding Date | Founding Date 2000 | Founding Date 2009 | Founding Date 2011 | Founding Date 2015 | Founding Date 2014 |
Type | Type Private | Type Public | Type Subsidiary | Type Public | Type Public |
Tags | |||||
Locations | Locations Birmingham, US HQ | Locations Dallas, US HQ San Francisco, US | Locations Woburn, US HQ Milton, GB Woburn, US | Locations Redwood City, US HQ Redwood City, US | |
Employees | Employees 7 | Employees 4843% increase | Employees 554% increase | Employees 10422% increase | Employees 37854% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 10.6 m | Valuation ($) N/A | Valuation ($) 823.3 m | Valuation ($) 8.4 b |
Financial | |||||
Net income | Net income N/A | Net income ($264.5m) (FY, 2021) | Net income ($36.1m) (FY, 2018) | Net income ($247.3m) (FY, 2025) | Net income ($1.1b) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 357m | Total funding raised $ 92.6m | Total funding raised $ 30m | Total funding raised $ 226m |

Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents.
View company
Peloton Therapeutics is involved in discovering and developing novel drugs for cancer treatments.
View company
Replimune Ltd. develops oncolytic immunotherapies for the treatment of cancer.
View companyRevolution Medicines (RevMed) is a clinical-stage oncology company that develops therapies for cancer patients.
View company